MAPT and Alzheimer disease: Previously, tau‐PET‐negative (by quantitative cut‐off) AD patients were found to have higher cross‐sectional MMSE scores,13 and tau‐PET‐negative MCI and AD dementia individuals were found to show less decline on MMSE.21